Posted by Clinical Lab Products | Dec 16, 2009 | Miscellaneous |
Research and Markets has announced the addition of Global Markets Direct’s new report “North America In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2015” to their offering.
Read MorePosted by Clinical Lab Products | Dec 15, 2009 | Miscellaneous |
DxNA announces that the FDA has granted Emergency Use Authorization (EUA) for its 2009 H1N1 influenza virus diagnostic test for use in DxNA’s GeneSTAT detection platform.
Read MorePosted by Clinical Lab Products | Dec 10, 2009 | Cancer, Infectious Diseases, Sexually Transmitted Diseases |
The cobas 4800 System combines CE-marked in vitro diagnostic tests for Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and human papillomavirus (HPV) testing with fully-automated sample preparation and real-time polymerase chain reaction (PCR) technology.
Read MorePosted by Clinical Lab Products | Dec 9, 2009 | Miscellaneous |
The market for personalized medicine in the US is already $232 billion, and it is projected to grow 11% annually, according to a new report published today by PricewaterhouseCoopers LLP, entitled The Science of Personalized Medicine: Translating the Promise into Practice.
Read MorePosted by Clinical Lab Products | Dec 7, 2009 | Cancer, Hematology & Serology, Hematology Instrumentation, Miscellaneous |
PLUS Diagnostics announced that it has expanded its specialty anatomic pathology services with the launch of a national hematology/oncology offering.
Read More